Clinical Pearls for the Care of Patients with CLL

ASCO 2020 Virtual Meeting/May 29-31, 2020
EHA 2020 Virtual Meeting/June 11-21, 2020
Highlights in CLL treatment from CCO’s coverage of ASCO 2020 and EHA 2020, selected by our expert faculty.
John Allan, MD
Jennifer R. Brown, MD, PhD
Format: Microsoft PowerPoint (.ppt)
File Size: 250 KB
Released: August 28, 2020

Acknowledgements

Supported by an educational grant from
AstraZeneca

Related Content

A downloadable slideset from Clinical Care Options (CCO) developed by expert faculty on the proper diagnosis and management of aTTP using the latest clinical guidelines

Paul Coppo, MD, PhD Released: December 8, 2021

CCO Conference Coverage of ASH 2021 with downloadable slides and experts’ commentaries of clinically relevant studies

John M. Burke, MD Amy E. DeZern, MD, MHS Shaji K. Kumar, MD Sagar Lonial, MD Peter Martin, MD Mark A. Schroeder, MD Sujit Sheth, MD B Douglas Smith B. Douglas Smith, MD Srdan Verstovsek, MD, PhD Eunice S. Wang, MD Released: December 8, 2021

Commentary on considerations affecting therapy recommendations for patients with myeloma in the evolving treatment landscape, from Clinical Care Options (CCO)

Brian G.M. Durie, MD
Program Director
Thomas G. Martin, MD Philippe Moreau, MD S. Vincent Rajkumar, MD Jesús F. San-Miguel, MD, PhD
Released: December 7, 2021

Commentary from Dr. Julie Vose on how to select therapy for patients with EBV-positive PTLD, from Clinical Care Options (CCO)

Julie M. Vose, MD, MBA Released: December 6, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue